Pfizer to present data across respiratory and other infectious …
网页17 小时之前 · Pfizer Inc. will present data across its infectious disease portfolio at the upcoming IDWeek 2024 congress, held in Los Angeles from October 16-19, 2024. Data in 49 abstracts from company- and collaborator-led studies, will highlight the advances Pfizer is making in helping prevent and treat ...
Bayer, MOMA Therapeutics ink collaboration to develop and …
网页13 小时之前 · Bayer and MOMA Therapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, announced that they have entered into a collaboration, under an option and exclusive license agreement, to develop and commercialize a small molecule ...
Leads Biolabs’ LBL-024 receives Breakthrough Therapy …
网页16 小时之前 · Nanjing Leads Biolabs Co., Ltd. (Leads Biolabs), a clinical-stage biotechnology company, announced that Center for Drug Evaluation (CDE) of National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation to LBL-024, an anti-PD-L1/4-1BB bispecific antibody independently ...
Simulations Plus and the University of Southern California secure …
网页15 小时之前 · Simulations Plus, Inc., a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, announced the award of a new research grant from the National Institutes of Health (NIH), secured in partnership with the ...
MvPI releases updated version of medical devices adverse event ...
网页18 小时之前 · Our Bureau, New Delhi. Thursday, October 10, 2024, 08:00 Hrs [IST] The Materiovigilance Programme of India (MvPI), under the Indian Pharmacopoeia Commission, has released the updated version of the medical devices adverse event reporting form, for the use of manufacturers, importers and distributors of …
Pfizer, BioNTech receive US FDA approval & authorization for …
网页Saturday, August 24, 2024, 09:00 Hrs [IST] Pfizer Inc. and BioNTech SE announced that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application for individuals 12 years of age and older (COMIRNATY (Covid-19 Vaccine, mRNA), and granted emergency use authorization for individuals 6 months through 11 ...
Eli Lilly announces positive topline results from the SURMOUNT-1 …
网页2024年8月22日 · Indianapolis. Thursday, August 22, 2024, 13:00 Hrs [IST] Eli Lilly and Company announced positive topline results from the SURMOUNT-1 three-year study (176-week treatment period) evaluating the efficacy and safety of tirzepatide (Zepbound and Mounjaro) once weekly for long-term weight management and delay in progression to diabetes in adults ...
Sun Pharma, Moebius Medical receives US FDA Fast Track …
网页2024年9月6日 · Sun Pharma, Moebius Medical receives US FDA Fast Track designation for MM-II to treat osteoarthritis knee pain: Our Bureau, Mumbai Friday, September 6, 2024, 16:25 Hrs [IST]
News - Pharmabiz.com
网页Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing.
IPC releases Indian Pharmacopoeia 2022 - Pharmabiz.com
网页2022年5月9日 · Laxmi Yadav, Mumbai. Monday, May 9, 2022, 08:00 Hrs [IST] In a bid to promote the highest standards of drugs for use in humans and animals, the Indian Pharmacopoeia Commission (IPC) has released Indian Pharmacopoeia 2022 containing 92 new monographs, 21 vitamins, minerals, amino acids, fatty acids and 27 active pharmaceutical ingredients (APIs).